Skip to main content

. 1983 May;38(5):396–398. doi: 10.1136/thx.38.5.396

Pleuropulmonary fibrosis associated with chronic and excessive intake of ergotamine.

B G Taal, E L Spierings, C Hilvering

PMCID: PMC459569 PMID: 6879492

396

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bana D. S., MacNeal P. S., LeCompte P. M., Shah Y., Graham J. R. Cardiac murmurs and endocardial fibrosis associated with methysergide therapy. Am Heart J. 1974 Nov;88(5):640–655. doi: 10.1016/0002-8703(74)90251-8. [DOI] [PubMed] [Google Scholar]
Fanciullacci M., Granchi G., Sicuteri F. Ergotamine and methysergide as serotonin partial agonists in migraine. Headache. 1976 Nov;16(5):226–231. doi: 10.1111/j.1526-4610.1976.hed1605226.x. [DOI] [PubMed] [Google Scholar]
Graham J. R., Suby H. I., LeCompte P. R., Sadowsky N. L. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med. 1966 Feb 17;274(7):359–368. doi: 10.1056/NEJM196602172740701. [DOI] [PubMed] [Google Scholar]
Spierings E. L., Saxena P. R. Antimigraine drugs and cranial arteriovenous shunting in the cat. Neurology. 1980 Jul;30(7 Pt 1):696–701. doi: 10.1212/wnl.30.7.696. [DOI] [PubMed] [Google Scholar]
Tournigand P., Di Marino V., Mercier C. Une cause rare de compression veineuse intra-abdominale la fibrose rétropéritonéale (à propos d'un cas) Phlebologie. 1974 Apr-Jun;27(2):161–165. [PubMed] [Google Scholar]
Vérin P., Bresque E., Vizdy A., Lagoutte F. Fibrose rétro-péritonéale et dérivés de l'ergot. Incidences ophtalmologiques. Bull Soc Ophtalmol Fr. 1974 Mar;74(3):281–286. [PubMed] [Google Scholar]

ACTIONS

RESOURCES